Skip to main content
SpringerLink
Log in

Influence of genetic variants in the apolipoprotein A5 and C3 gene on lipids, lipoproteins, and its association with coronary artery disease in Indians

  • Original Article
  • Published:
Journal of Community Genetics Aims and scope Submit manuscript

Abstract

Indians worldwide demonstrate a triad of elevated triglyceride (TG) with high low-density lipoprotein cholesterol and low high-density lipoprotein cholesterol levels. In the present study, we aim to investigate the effect of −1131T > C, −3A > G, c.56 C > G, and c.553 G > T SNPs in the apolipoprotein A5 (APOA5) gene and 1100C > T and 3238C > G in the apolipoprotein C3 (APOC3) on plasma lipid and lipoprotein levels and risk of coronary artery disease (CAD) in Indians. Genotyping and lipid assays were carried out using standard protocols in a study population that included 150 controls and 90 cases with CAD. Significant associations between minor alleles and higher TG levels were seen for −1131T > C (P < 0.001), −3A > G (P < 0.001), c.56C > G (P = 0.026), and c.553G > T (P = 0.003) SNPs in the APOA5 gene and 1100C > T (P = 0.001) and 3238C > G (P = 0.009) in the APOC3 gene. The haplotypes 11211, 22111, 11112, and 22112 were significantly associated with TG levels (P = 0.025, P = 0.017, P = 0.027, and P < 0.001, respectively) and very-low-density lipoprotein cholesterol levels (P = 0.025, P = 0.017, P < 0.001, and P = 0.002) in males. The 22111, 11112, and 22112 were associated with elevated TG (P = 0.030, P = 0.036, and P = 0.024) but not VLDL-C levels in females. No association with other lipid parameters was seen. In the logistic regression model, the rare S2 allele was a significant risk factor (P = 0.030, 95% CI 1.186–31.432) along with smoking (P < 0.0001, 95% CI 2.018–10.397) for CAD. The APOA5 and APOC3 locus is a strong determinant of plasma TG levels in Indians. The APOC3 3238G is a risk factor for CAD and a higher frequency was also seen with type 2 diabetes mellitus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  • Assmann G, Schulte H, von Eckardstein A (1996) Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. Am J Cardiol 7(14):1179–1184

    Article  Google Scholar 

  • Austin MA (1991) Plasma triglyceride and coronary heart disease. Arterioscler Thromb 11(1):2–14

    PubMed  CAS  Google Scholar 

  • Chandak GR, Ward KJ, Yajnik CS et al (2006) Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune. India compared to Europeans. BMC Med Genet 7:33

    Article  CAS  Google Scholar 

  • Chhabra S, Narang R, Lakshmy R et al (2004) Apolipoprotein C3 SstI polymorphism in the risk assessment of CAD. Mol Cell Biochem 259(1–2):59–66

    Article  PubMed  CAS  Google Scholar 

  • Dallongeville J, Cottel D, Montaye M, Codron V, Amouyel P, Helbecque N (2006) Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men. Int J Cardiol 106:152–156

    Article  PubMed  Google Scholar 

  • Dammerman M, Sandkuijl LA, Halaas JL, Chung W, Breslow JL (1993) An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3′ untranslated region polymorphisms. Proc Natl Acad Sci USA 90(10):4562–4566

    Article  PubMed  CAS  Google Scholar 

  • Grallert H, Sedlmeier EM, Huth C et al (2007) APOA5 variants and metabolic syndrome in Caucasians. J Lipid Res 48(12):2614–2621

    Article  PubMed  CAS  Google Scholar 

  • Groenendijk MR, Cantor M, deBruin TW, Dallinga-Thie GM (2001) The apoAI-CIII-AIV gene cluster. Atherosclerosis 157:1–11

    Article  PubMed  CAS  Google Scholar 

  • Hodoglugil U, Tanyolac S, Williamson DW, Huang Y, Mahley RW (2006) Apolipoprotein A-V: a potential modulator of plasma triglyceride levels in Turks. J Lipid Res 47:144–153

    Article  PubMed  CAS  Google Scholar 

  • Hokanson JE, Austin MA (1996) Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 3:213–219

    Article  PubMed  CAS  Google Scholar 

  • Hsu LA, Ko YL, Chang CJ et al (2006) Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan. Atherosclerosis 185:143–149

    Article  PubMed  CAS  Google Scholar 

  • Ito Y, Azrolan N, O’Connell A, Walsh A, Breslow JL (1990) Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science 249:790–793

    Article  PubMed  CAS  Google Scholar 

  • Kao JT, Wen HC, Chien KL, Hsu HC, Lin SW (2003) A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia. Hum Mol Genet 12:2533–2539

    Article  PubMed  CAS  Google Scholar 

  • Ko YL, Ko YS, Wu SM et al (1997) Interaction between obesity and genetic polymorphisms in the apolipoprotein CIII gene and lipoprotein lipase gene on the risk of hypertriglyceridemia in Chinese. Hum Genet 100:327–333

    Article  PubMed  CAS  Google Scholar 

  • Lai CQ, Tai ES, Tan CE et al (2003) The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore. J Lipid Res 44:2365–2373

    Article  PubMed  CAS  Google Scholar 

  • Lai CQ, Demissie S, Cupples A et al (2004) Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the framingham heart study. J Lipid Res 45:2096–2105

    Article  PubMed  CAS  Google Scholar 

  • Maeda N, Li H, Lee D, Oliver P, Quarfordt SH, Osada J (1994) Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia. J Biol Chem 269:23610–23616

    PubMed  CAS  Google Scholar 

  • Martin S, Nicaud V, Humphries SE, Talmud PJ (2003) Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges. Biochim Biophys Acta 1637:217–225

    PubMed  CAS  Google Scholar 

  • Martinelli N, Trabetti E, Bassi A et al (2007) The −1131T > C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study. Atherosclerosis 191(2):409–417

    Article  PubMed  CAS  Google Scholar 

  • Mc Keigue PM, Miller GJ, Marmot MG (1989) Coronary heart disease in South-Asians overseas: a review. J Clin Epidemiol 41:597–609

    Article  Google Scholar 

  • Paul-Hayase H, Rosseneu M, Robinson D, van Bervliet JP, Deslypere JP, Humphries SE (1992) Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations. Hum Genet 88:439–446

    Article  PubMed  CAS  Google Scholar 

  • Pennacchio LA, Rubin EM (2003) Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice. Arterioscler Thromb Vasc Biol 23:529–534

    Article  PubMed  CAS  Google Scholar 

  • Pennacchio LA, Olivier M, Hubacek JA et al (2001) An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294:169–173

    Article  PubMed  CAS  Google Scholar 

  • Pennacchio LA, Olivier M, Hubacek J, Krauss RM, Rubin EM, Cohen JC (2002) Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet 11:3031–3038

    Article  PubMed  CAS  Google Scholar 

  • Rees A, Shoulders CC, Stocks J, Galton DJ, Baralle FE (1983) DNA polymorphism adjacent to human apolipoprotein A-1 gene: relation to hypertriglyceridemia. Lancet 1:444–446

    Article  PubMed  CAS  Google Scholar 

  • Ruiz-Narváez EA, Yang Y, Nakanishi Y, Kirchdorfer J, Campos H (2005) APOC3/A5 haplotypes, lipid levels, and risk of myocardial infarction in the Central Valley of Costa Rica. J Lipid Res 46:2605–2613

    Article  PubMed  CAS  Google Scholar 

  • Russo GT, Meigs JB, Cupples A et al (2001) Association of the Sst-I polymorphism at the APOC 3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study. Atherosclerosis 158:173–181

    Article  PubMed  CAS  Google Scholar 

  • Sarwar N, Danesh J, Eiriksdottir G et al (2007) Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation 115(4):450–458

    Article  PubMed  CAS  Google Scholar 

  • Shanker J, Perumal G, Rao VS et al (2008) Genetic studies on the APOA1-C3-A5 gene cluster in Asian Indians with premature coronary artery disease. Lipids Health Dis 7:33

    Article  PubMed  CAS  Google Scholar 

  • Szalai C, Keszei M, Duba J et al (2004) Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with increased susceptibility for coronary artery disease. Atherosclerosis 173:109–114

    Article  PubMed  CAS  Google Scholar 

  • Talmud PJ, Hawe E, Martin S et al (2002) Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet 11(24):3039–3046

    Article  PubMed  CAS  Google Scholar 

  • Talmud PJ, Martin S, Taskinen MR et al (2004) APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study. J Lipid Res 45:750–756

    Article  PubMed  CAS  Google Scholar 

  • Tang YP, Sun D, Guo A, Ji Ferro Y, Chen Q, Fan L (2006) A genetic variant c.553G > T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population. Atherosclerosis 185:433–437

    Article  PubMed  CAS  Google Scholar 

  • Vaessen SFC, Schaap FG, Kuivenhoven JA et al (2006) Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective EPIC-Norfolk Population Study. J Lipid Res 47:2064–2070

    Article  PubMed  CAS  Google Scholar 

  • Waterworth DM, Ribalta J, Nicaud V, Dallongville J, Humphries SE, Talmud P (1999) ApoCIIIgene variants modulate post-prandial response to both glucose and fat tolerance tests. Circulation 99:1872–1877

    PubMed  CAS  Google Scholar 

  • Waterworth DM, Talmud PJ, Bujac SR, Fisher RM, Miller GJ, Humphries SE (2000) Contribution of Apolipoprotein C-III gene variants to determination of triglyceride levels and interaction with smoking in middle-aged men. Arterioscler Thromb Vasc Biol 20:2663–2669

    PubMed  CAS  Google Scholar 

  • Wong WR, Hawe E, Li LK et al (2003) Apolipoprotein AIV gene variant is associated with increased risk of coronary heart disease and lower ApoAIV plasma concentrations. Circ Res 92:969–972

    Article  PubMed  CAS  Google Scholar 

  • Zeng Q, Dammerman M, Takada Y, Matsunaga A, Breslow JL, Sasaki J (1995) An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population. Hum Genet 95:371–375

    Article  PubMed  CAS  Google Scholar 

  • Ordovas JM (2007) Gender, a significant factor in the cross talk between genes, environment, and health. Gend Med 4(Suppl B):111–121

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research and Development, Super Religare laboratories, Prime Square Building, Plot No 1 S. V. Road, Goregaon (W), Mumbai, 400062, India

    Aparna A. Bhanushali & Bibhu R. Das

Authors
  1. Aparna A. Bhanushali
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bibhu R. Das
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bibhu R. Das.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bhanushali, A.A., Das, B.R. Influence of genetic variants in the apolipoprotein A5 and C3 gene on lipids, lipoproteins, and its association with coronary artery disease in Indians. J Community Genet 1, 139–148 (2010). https://doi.org/10.1007/s12687-010-0025-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12687-010-0025-x

Keywords

Search

Navigation